Stock Earnings

Question 1

What are Dyne Therapeutics, Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Dyne Therapeutics, Inc has a total asset of $1,186, Net loss of $-446

Question 2

What are the key financial ratios for DYN?

Accepted Answer

Dyne Therapeutics, Inc's Current ratio is 5.54, has a Net margin is 0, sales per share of $0.

Question 3

How is Dyne Therapeutics, Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Dyne Therapeutics, Inc data is not available.

Question 4

Is Dyne Therapeutics, Inc profitable?

Accepted Answer

no, according to the latest financial statements, Dyne Therapeutics, Inc has a net loss of $-446

Question 5

Does Dyne Therapeutics, Inc have any liabilities?

Accepted Answer

yes, Dyne Therapeutics, Inc has liability of 214

Question 6

How many outstanding shares for Dyne Therapeutics, Inc?

Accepted Answer

Dyne Therapeutics, Inc has a total outstanding shares of 164.95

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	78	69	62	31	28	28
Research & Development	392	398	281	210	142	121
Operating Expenses	471	468	343	242	170	150
Other Non Operating Income (Expenses)	-1	-1	0	-1	0	0
Pretax Income	-451	-446	-317	-235	-168	-149
Income Tax Expense	--	0	--	--	--	--
Net Income	-451	-446	-317	-235	-168	-149
Net Income Growth	23%	41%	35%	40%	13%	153%
Shares Outstanding (Diluted)	165.03	128.44	94.14	59.68	51.98	50.9
Shares Change (YoY)	50%	36%	57.99%	15%	2%	13%
EPS (Diluted)	-2.73	-3.47	-3.37	-3.95	-3.23	-2.93
EPS Growth	-18%	3%	-15%	22%	10%	122%
Free Cash Flow	-462	-423	-294	-188	-156	-123
Free Cash Flow Per Share	-2.79	-3.29	-3.12	-3.14	-3	-2.41
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-469	-466	-342	-241	-169	-149
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	2	2	1	1	1	1
EBIT	-471	-468	-343	-242	-170	-150
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Dyne Therapeutics, Inc (DYN) Price